'Spider-Man: No Way Home' hits $669M, climbs to No. 6 in all-time U.S. box office

Lindsay Bahr
The Associated Press

The glamorous spies of "The 355" were no competition for the movie theater's reigning web-slinger. 

The box-office dominance of "Spider-Man: No Way Home" continued in its fourth weekend in theaters, adding another $33 million, according to studio estimates on Sunday. With $668.8 million in North American ticket sales to date, "No Way Home" is now the sixth highest-grossing release of all time domestically. Globally, with $1.5 billion and counting, it ranks in eighth place. 

The only major new film this weekend was "The 355," a spy thriller starring Jessica Chastain, Lupita Nyong'o, Diane Kruger and Penelope Cruz, which debuted in third place with $4.8 million from 3,145 North American theaters. Directed by Simon Kingberg, reviews for the film about a global coalition of female spies have been less than stellar: It holds a 27% fresh rating on Rotten Tomatoes.

From 'Encanto' to 'Being the Ricardos': Here's what you need to stream right now

A returning Doc Ock (Alfred Molina, left) and Spider-Man (Tom Holland) duke it it out in "Spider-Man: No Way Home."

But the audience scores have been more enthusiastic, especially from women, and about a third of the attendees this weekend were over 45 – a demographic that has not gone out to movie theaters much during the pandemic. With the Martin Luther King Jr. holiday weekend coming up, "we think we'll have a nice runway," says Jim Orr, Universal's head of domestic distribution.

"The 355" came in behind the animated "Sing 2," which grossed an estimated $12 million in its third weekend in theaters, bringing its global total to $190.8 million. 

The 10 most must-see movies of 2022: From 'The Batman' to 'Top Gun: Maverick'

With omicron cases surging, Hollywood has entered 2022 cautiously. January's biggest new release, the Spider-Man spinoff "Morbius," was recently pushed to April

"There's a bit of uncertainty in the marketplace because of the omicron variant," says Paul Dergarabedian, Comscore's senior media analyst. "Studios want to protect their crown jewels and give them the greatest shot at success in movie theaters. A delay like that shows they're not giving up on the theaters. But studios are very aware of this marketplace and what the challenges might be."

And while January is now destined to be quiet at the box office, Dergarabedian says Spider-Man has been a "beacon of hope" for the industry.

"It shows that audiences want to go back to the movie theater," he says. "We could end up having a really strong box office year."

Final figures are expected Monday.

Contributing: Kim Willis, USA TODAY

Oscar season chaos: How omicron has created the most 'confusing' awards season yet